Home > News > DermAvance Acquires Hyalogy(TM)
August 16th, 2006
DermAvance Acquires Hyalogy(TM)
Abstract:
DermAvance Pharmaceuticals, a privately held pharmaceutical company specializing in advanced technology
applications for skin health and cosmetic dermatology, today announced the acquisition of the North American rights for the Hyalogy(TM) Total Skin Care Line from Forlle'd in Japan.
Source:
prnewswire
Bookmark:
Announcements
Less is More: Novel Cellulose Structure Requires Fewer Enzymes to Process Biomass to Fuel June 19th, 2013
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Personal Care
Lorraine University uses Nanoparticle Tracking Analysis to characterize biomolecules for agrichemicals, pharmacology and cosmetics May 28th, 2013
New synthesis method produces nanoparticles in high quantities February 25th, 2013
Harris & Harris Group Notes Solazyme and Mitsui Multi-Year Agreement February 7th, 2013
X-rays reveal uptake of nanoparticles by soya bean crops: Metals contained in nanoparticles can enter into the food chain February 6th, 2013